Stay updated on LDL Lowering in Stable CV Disease: High Intensity Clinical Trial
Sign up to get notified when there's something new on the LDL Lowering in Stable CV Disease: High Intensity Clinical Trial page.

Latest updates to the LDL Lowering in Stable CV Disease: High Intensity Clinical Trial page
- Check6 days agoChange DetectedThe history page adds a 'Show glossary' option and color-coded indicators for additions and deletions, and updates the revision tag to v3.4.0 with No FEAR Act Data adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check19 days agoChange DetectedRevision v3.3.4 was added and revision v3.3.3 was removed from the record history.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' link along with 'Revision: v3.3.2' were removed from the footer.SummaryDifference0.2%

- Check63 days agoChange DetectedThe History section shows a new Revision: v3.3.2 added and Revision: v3.3.1 removed, which are administrative updates to the page's version history rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now shows the addition of revision v3.3.1 and the removal of revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedDeleted a notice about government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to LDL Lowering in Stable CV Disease: High Intensity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LDL Lowering in Stable CV Disease: High Intensity Clinical Trial page.